These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29083978)

  • 1. Immunotherapy regimens for metastatic colorectal carcinomas.
    Bashir B; Snook AE
    Hum Vaccin Immunother; 2018 Feb; 14(2):250-254. PubMed ID: 29083978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Expanding Role for Immunotherapy in Colorectal Cancer.
    Bever KM; Le DT
    J Natl Compr Canc Netw; 2017 Mar; 15(3):401-410. PubMed ID: 28275038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results and challenges of immune checkpoint inhibitors in colorectal cancer.
    Emambux S; Tachon G; Junca A; Tougeron D
    Expert Opin Biol Ther; 2018 May; 18(5):561-573. PubMed ID: 29471676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring immunotherapy in colorectal cancer.
    Weng J; Li S; Zhu Z; Liu Q; Zhang R; Yang Y; Li X
    J Hematol Oncol; 2022 Jul; 15(1):95. PubMed ID: 35842707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for Colorectal Cancer.
    Mukherji R; Weinberg BA; Pedersen KS
    Hematol Oncol Clin North Am; 2022 Jun; 36(3):603-626. PubMed ID: 35577706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives.
    Gandini A; Puglisi S; Pirrone C; Martelli V; Catalano F; Nardin S; Seeber A; Puccini A; Sciallero S
    Front Oncol; 2023; 13():1161048. PubMed ID: 37207140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Verge: Immunotherapy for Colorectal Carcinoma.
    Oh DY; Venook AP; Fong L
    J Natl Compr Canc Netw; 2015 Aug; 13(8):970-8. PubMed ID: 26285242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-based immunotherapy in colorectal cancer.
    Feng M; Zhao Z; Yang M; Ji J; Zhu D
    Cancer Lett; 2021 Feb; 498():201-209. PubMed ID: 33129958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.
    Advani S; Kopetz S
    J Surg Oncol; 2019 Apr; 119(5):642-652. PubMed ID: 30852840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):26-34. PubMed ID: 29120224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role of immune oncology in colorectal cancer.
    Dawood S
    Chin Clin Oncol; 2018 Apr; 7(2):17. PubMed ID: 29764162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of immunotherapy with PD-1 inhibitor in colorectal cancer: a meta-analysis.
    He S; Hu D; Feng H; Xue Y; Jin J; Wang X
    J Comp Eff Res; 2020 Dec; 9(18):1285-1292. PubMed ID: 33073605
    [No Abstract]   [Full Text] [Related]  

  • 13. Combating colorectal cancer with immunotherapy: Where are we?
    Gupta R; Bhatt LK; Prabhavalkar KS
    Drugs Today (Barc); 2019 Aug; 55(8):513-528. PubMed ID: 31461088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy of Colorectal and Anal Carcinoma].
    Tomášek J; Kiss I
    Klin Onkol; 2017; 30(Supplementum3):62-65. PubMed ID: 29239195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives.
    Cui G
    Biomed Pharmacother; 2022 May; 149():112923. PubMed ID: 36068782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
    Kather JN; Halama N; Jaeger D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of immune checkpoint inhibitor in colorectal cancer].
    Kitano S
    Nihon Rinsho; 2016 Nov; 74(11):1818-1820. PubMed ID: 30550688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapies catering to the unmet medical need of cold colorectal cancer.
    Yuan J; Li J; Gao C; Jiang C; Xiang Z; Wu J
    Front Immunol; 2022; 13():1022190. PubMed ID: 36275766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of immunotherapy in metastatic colorectal cancer.
    Wrobel P; Ahmed S
    Int J Colorectal Dis; 2019 Jan; 34(1):13-25. PubMed ID: 30465238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.